| __timestamp | Dr. Reddy's Laboratories Limited | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 2917513 |
| Thursday, January 1, 2015 | 42585000000 | 7878291 |
| Friday, January 1, 2016 | 45702000000 | 8366794 |
| Sunday, January 1, 2017 | 46372000000 | 6610381 |
| Monday, January 1, 2018 | 46910000000 | 6556000 |
| Tuesday, January 1, 2019 | 48890000000 | 6930000 |
| Wednesday, January 1, 2020 | 50129000000 | 8758000 |
| Friday, January 1, 2021 | 54559000000 | 10806000 |
| Saturday, January 1, 2022 | 62081000000 | 9844000 |
| Sunday, January 1, 2023 | 105931000000 | 13481000 |
| Monday, January 1, 2024 | 77201000000 |
Unveiling the hidden dimensions of data
In the world of pharmaceuticals and biotechnology, understanding the financial health of companies is crucial. Dr. Reddy's Laboratories Limited, a major player in the pharmaceutical industry, has shown a remarkable increase in its Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, their SG&A expenses surged by approximately 173%, peaking in 2023. This growth reflects their expanding operations and market reach.
In contrast, Soleno Therapeutics, Inc., a smaller biotech firm, has maintained relatively stable SG&A expenses, with a modest increase of about 362% over the same period. This stability suggests a focused approach to managing operational costs while navigating the challenges of the biotech sector.
The data highlights the contrasting financial strategies of these two companies, offering insights into their operational priorities and market positioning.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Soleno Therapeutics, Inc.
Merus N.V. vs Soleno Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for HUTCHMED (China) Limited and Soleno Therapeutics, Inc.